Tag: Vaccine
-
Canada braces for a tough flu season as evolving H3N2 strain challenges the vaccine
Canada Faces a Potentially Severe Flu Season Canada is preparing for what many experts are warning could be one of the worst influenza seasons in years. The concern centers on an evolving H3N2 strain that has been spreading globally and may not be a good match for this year’s vaccine. As flu cases rise, doctors…
-
SUM-101 Malaria Vaccine Shows Strong Immune Response
Overview of the SUM-101 Trial A new experimental malaria vaccine known as SUM-101 has generated hopeful results in its initial testing phase. Conducted among Tanzanian adults who have lived with malaria exposure, the early trial aimed to assess the vaccine’s safety and its ability to stimulate the immune system — a key step before larger…
-
Foot-and-Mouth Disease Vaccine Doses Now Available in SA
Overview In a move set to impact South Africa’s livestock sector, the Botswana Vaccine Institute (BVI) has made an additional 70,000 doses of the foot-and-mouth disease (FMD) vaccine available for purchase on the local market. The announcement was confirmed by Dewald Olivier, CEO of Red Meat Industry Services (RMIS), as part of ongoing efforts to…
-
Mpox Clade Ib Spreads in Europe: Why Vaccination Remains Key
Mpox Clade Ib: A new reminder for vaccination Health authorities in Europe are raising alarms as the mpox (monkeypox) landscape shifts with the emergence of clade Ib cases in several countries. While mpox has historically affected different populations, recent reporting shows small numbers of clade Ib infections in Portugal, Spain, Italy, the Netherlands, and the…
-
Triple-action vaccine shows promise against typhoid and invasive Salmonella in Phase 1 trial
New Phase 1 results offer hope for a dual-protection vaccine A novel trivalent vaccine designed to guard against both typhoid fever and invasive non-typhoidal Salmonella (iNTS) infections has demonstrated encouraging safety and immune responses in a Phase 1 human trial. The study, led by researchers from the University of Maryland (UM) School of Medicine in…
-
What Data TAG-CO-VAC Will Use for December 2025 COVID-19 Vaccine Antigen Decisions
Overview The World Health Organization’s Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC) is preparing for its December 2025 decision-making meeting. The group continuously monitors the genetic and antigenic evolution of SARS-CoV-2 variants, immune responses following infection and vaccination, and the performance of currently authorized vaccines against circulating strains. The goal is to guide vaccine…
-
COVID-19 Vaccine Access for Pregnant Albertans: What You Need to Know
COVID-19 Vaccine Availability for Pregnant Albertans Pregnant Albertans are now eligible for a free COVID-19 vaccine this fall, a crucial opportunity for protecting both mothers and their unborn children. However, recent warnings from healthcare professionals highlight a concerning gap in communication from the provincial government regarding this important public health initiative. Lack of Awareness Among…
-
Free COVID-19 Vaccine for Pregnant Albertans: Important Update
COVID-19 Vaccine Availability for Pregnant Albertans This fall, pregnant Albertans can take advantage of a significant public health initiative: the availability of a free COVID-19 vaccine. With growing concerns about the COVID-19 virus affecting vulnerable populations, particularly pregnant individuals, health officials have made it clear that vaccination is a priority. However, many pregnant Albertans may…
-
First Vaccine Approved to Protect Australian Koalas from Chlamydia
Introduction to Koalas and Chlamydia Koalas, one of Australia’s most iconic animals, are facing a serious threat from chlamydia, a sexually transmitted disease that has led to substantial population declines. This condition not only affects their reproductive health but can also cause serious illnesses and even lead to death. Recent developments have brought a glimmer…